Csenge Advisory Group Masimo Corp Transaction History

Csenge Advisory Group

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$208.49 - $248.2 $498,916 - $593,942	-2,393 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$220.31 - $283.75 $68,957 - $88,813	313 Added 15.05%	2,393 $560,000
Q4 2020 Jan 26, 2021	BUY	$223.82 - $271.35 $11,414 - $13,838	51 Added 2.51%	2,080 $558,000
Q3 2020 Nov 09, 2020	BUY	$209.49 - $246.81 $57,609 - $67,872	275 Added 15.68%	2,029 $487,000
Q2 2020 Jul 17, 2020	SELL	$178.49 - $250.39 $5,711 - $8,012	-32 Reduced 1.79%	1,754 $400,000
Q1 2020 Apr 21, 2020	BUY	$148.38 - $186.78 $18,399 - $23,160	124 Added 7.46%	1,786 $316,000
Q4 2019 Feb 05, 2020	BUY	$140.81 - $159.49 $28,302 - $32,057	201 Added 13.76%	1,662 $263,000
Q3 2019 Nov 14, 2019	BUY	$145.61 - $159.87 $5,387 - $5,915	37 Added 2.6%	1,461 $217,000
Q2 2019 Jul 30, 2019	BUY	$122.29 - $148.82 $174,140 - $211,919	1,424 New	1,424 $212,000
Q4 2018 Feb 07, 2019	SELL	$98.38 - $125.32 $13,674 - $17,419	-139 Closed	0 $0
Q3 2018 Nov 19, 2018	BUY	$97.19 - $124.54 $13,509 - $17,311	139 New	139 $15,000

395

43.1M

310K

268K

Ticker MASI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 52,530,200
Market Cap $9.14B
Description
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximet...

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

Stay updated on Csenge Advisory Group with notifications on news.